Loading...
•
Jun 30, 2023
Hims & Hers Q2 2023 Earnings Report
Hims & Hers experienced revenue growth and improved profitability.
Key Takeaways
Hims & Hers Health, Inc. reported strong second-quarter results with significant revenue growth of 83% year-over-year, reaching $207.9 million. The company also achieved Adjusted EBITDA profitability of $10.6 million and subscriber growth to 1.3 million. The company raised its full-year revenue guidance to $830 million to $850 million and Adjusted EBITDA guidance to $35 million to $40 million.
Revenue increased by 83% year-over-year to $207.9 million.
The company achieved Adjusted EBITDA profitability of $10.6 million.
Subscribers grew by 74% year-over-year to 1.3 million.
Full-year revenue guidance raised to $830 million - $850 million.
Revenue by Segment
Forward Guidance
Hims & Hers provided revenue guidance of $217 million to $222 million and Adjusted EBITDA guidance of $10 million to $13 million for Q3 2023. For the full year 2023, the company expects revenue of $830 million to $850 million and Adjusted EBITDA of $35 million to $40 million.
Positive Outlook
- Revenue of $217 million to $222 million for Q3 2023.
- Adjusted EBITDA of $10 million to $13 million for Q3 2023.
- Revenue of $830 million to $850 million for the full year 2023.
- Adjusted EBITDA of $35 million to $40 million for the full year 2023.
- Adjusted EBITDA margin of 4% to 5% for the full year 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...